SOX2 and urothelial carcinoma: Consistent with previous gene expression results, SOX2, the key gene regulator of pluripotency, was detectable in about 30% of the urothelial carcinoma, thus emphasizing the presence of different stem-like and differentiated cell populations within the bladder carcinoma.